{"id":2956,"date":"2024-08-10T13:28:11","date_gmt":"2024-08-10T13:28:11","guid":{"rendered":"https:\/\/d.ptpl.dev\/acarix\/?page_id=2956"},"modified":"2026-05-08T15:38:33","modified_gmt":"2026-05-08T10:08:33","slug":"press","status":"publish","type":"page","link":"https:\/\/d.ptpl.dev\/acarix\/press\/","title":{"rendered":"Press"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2956\" class=\"elementor elementor-2956\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"wd-negative-gap elementor-element elementor-element-87e5c5e wd-section-stretch e-flex e-con-boxed e-con e-parent\" data-id=\"87e5c5e\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-172f0ed e-con-full e-flex e-con e-child\" data-id=\"172f0ed\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e9c914f elementor-widget__width-auto elementor-widget-mobile_extra__width-initial elementor-widget-mobile__width-inherit elementor-widget elementor-widget-heading\" data-id=\"e9c914f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Press<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"wd-negative-gap elementor-element elementor-element-3110195 wd-section-stretch e-flex e-con-boxed e-con e-parent\" data-id=\"3110195\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1ceab76 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"1ceab76\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Press<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f5816fb e-con-full e-flex e-con e-child\" data-id=\"f5816fb\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cc9fb69 elementor-widget elementor-widget-shortcode\" data-id=\"cc9fb69\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\"><div class=\"mfn-newsfeed\"><form method=\"GET\" id=\"mfn-filter-form\"><div class=\"mfn-filter-container\"><div class=\"mfn-newsfeed-category-selector\"><script>\n                    function filterByCategory(e)\n                    {\n                        var type = e.getAttribute(\"filtertype\");\n                        var instance_id = document.getElementById(\"instance_id\").value;\n                        var q = document.getElementById(\"current_category_query\").value;\n                        if (type === \"dropdown\") {\n                            var el = document.getElementById(\"mfn-category-filter-\"  + instance_id);\n                            if (e.value !== \"\") q += \"&m-tags=\" + e.value;\n                            el.value = document.getElementById(\"category_tag\").value;\n                        } else if (type === \"buttons\") {\n                            if (e.value !== \"\") q += \"&m-tags=\" + e.value;\n                        }\n                        window.location.href = q;\n                        return false;\n                    }\n                 <\/script>\n                 <label for=\"mfn-category-filter-1617955071\" class=\"mfn-category-label\">Category<\/label>    <div id=\"mfn-category-filter-1617955071\" class=\"mfn-category-filter\">    <button type=\"button\" value=\"\" class=\"mfn-category-button-all mfn-filter-button-active\" filtertype=\"buttons\" onclick=\"filterByCategory(this);\">All<\/button>    <button type=\"button\" value=\"regulatory\" class=\"mfn-category-button-regulatory\" filtertype=\"buttons\" onclick=\"filterByCategory(this);\">Regulatory<\/button>    <button type=\"button\" value=\"-regulatory\" class=\"mfn-category-button-non-regulatory\" filtertype=\"buttons\" onclick=\"filterByCategory(this);\">Non-Regulatory<\/button>    <\/div>  <input type=\"hidden\" id=\"current_category_query\" value=\"?\" \/>  <input type=\"hidden\" id=\"category_tag\" value=\"\" \/><\/div><\/div>  <input type=\"hidden\" id=\"instance_id\" value=\"1617955071\" \/><\/form><div class=\"mfn-list\">\n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-05-18 22:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/kallelse-till-arsstamma-i-acarix-ab-18\/'>KALLELSE TILL \u00c5RSST\u00c4MMA I Acarix AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Aktie&auml;garna i Acarix AB, org.nr 559009-0667 (&rdquo;Bolaget&rdquo;) kallas h&auml;rmed till &aring;rsst&auml;mma onsdagen den 17 juni 2026 kl. 14.00 i Advokatfirman Lindahls<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-05-18 22:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/notice-of-annual-general-meeting-in-acarix-ab-19\/'>NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the &ldquo;Company&rdquo;) are hereby convened to an annual general meeting on Wednesday 17 June<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-05-18 08:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-publishes-interim-report-january-march-2026\/'>Acarix Publishes Interim Report, January \u2013 March 2026<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-05-04 14:23<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-changes-publication-date-for-q1-2026-interim-report\/'>Acarix Changes Publication Date for Q1 2026 Interim Report<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix (ticker: Acarix) hereby announces that the company is postponing the release of its interim report for the first quarter of 2026.<\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-05-04 14:23<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-andrar-datum-for-publicering-av-delarsrapport-for-q1-2026\/'>Acarix \u00e4ndrar datum f\u00f6r publicering av del\u00e5rsrapport f\u00f6r Q1 2026<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix (ticker: Acarix) meddelar h&auml;rmed att bolaget flyttar fram publiceringstidpunkten f&ouml;r del&aring;rsrapporten f&ouml;r det f&ouml;rsta kvartalet 2026.<\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-04-15 13:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-abs-arsredovisning-2025\/'>Acarix AB\u2019s \u00c5rsredovisning 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix, ledande inom AI och avancerad akustikbaserad hj&auml;rtdiagnostik, meddelar idag att &aring;rsredovisning f&ouml;r 2025 finns tillg&auml;nglig som pdf p&aring; bolagets<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-04-15 13:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-abs-annual-report-2025\/'>Acarix AB\u2019s Annual Report 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2025 is available as a pdf on<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-04-07 13:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-presents-abstract-at-acc-26-highlighting-cadscor-systems-diagnostic-utility-compared-to-standard-stress-tests-in-chest-pain-patients\/'>ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR\u00ae SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Findings demonstrate high NPV, care time savings of up to 40 hours, and cost reductions exceeding $100,000 per inpatient case, reinforcing the commercial<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-02-12 08:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-publishes-year-end-report-2025\/'>Acarix Publishes Year-End Report 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. &ldquo;Last year<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-02-11 09:20<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-announces-new-distribution-partner-in-saudi-arabia-for-the-cadscor-system\/'>Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-02-04 09:20<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-receives-eu-mdr-certification-for-the-cadscorsystem\/'>Acarix Receives EU MDR Certification for the CADScor\u00aeSystem<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-12-08 08:47<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-carries-out-a-directed-share-issue-of-approx-sek-33-4-million\/'>ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        \n            <span class='mfn-tag mfn-tag-mfn-regulatory-mar'>MAR<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>The Board of Directors of Acarix AB (publ) (&quot;Acarix&quot; or the &quot;Company&quot;) has today resolved to carry out a directed share issue of maximum 117,236,844 shares<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-12-08 08:47<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-genomfor-en-riktad-emission-om-cirka-334-msek\/'>ACARIX GENOMF\u00d6R EN RIKTAD EMISSION OM CIRKA 33,4 MSEK<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        \n            <span class='mfn-tag mfn-tag-mfn-regulatory-mar'>MAR<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Styrelsen i Acarix AB (publ) (&rdquo;Acarix&rdquo; eller &rdquo;Bolaget&rdquo;) har idag beslutat om att genomf&ouml;ra en riktad nyemission av h&ouml;gst 117 236 844 aktier till<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-06 08:45<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-third-quarter-2025-report\/'>Invitation to presentation of Acarix\u00b4s third quarter 2025 report<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast presentation of the<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-06 08:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-tredje-kvartalet-2025\/'>Acarix AB (publ) publicerar tredje kvartalet 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, redovisade idag sina finansiella resultat f&ouml;r det tredje kvartalet 2025<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-06 08:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-publishes-interim-report-third-quarter-2025\/'>Acarix Publishes Interim Report, Third quarter 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the third quarter<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-27 15:35<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/announcement-from-the-general-meeting-in-acarix-ab\/'>Announcement from the general meeting in Acarix AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>The extraordinary general meeting 2025 (the &quot;EGM&quot;) of Acarix AB (&quot;Acarix&quot; or the &quot;Company&quot;) was held today on 27 October 2025 and the following resolutions<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-27 15:35<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/kommunike-fran-extra-bolagsstamma-i-acarix-ab\/'>Kommunik\u00e9 fr\u00e5n extra bolagsst\u00e4mma i Acarix AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Extra bolagsst&auml;mma i Acarix AB (&quot;Acarix&quot; eller &quot;Bolaget&quot;) h&ouml;lls idag den 27 oktober 2025 varvid aktie&auml;garna fattade besluten nedan.<\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-24 15:15<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-ab-byter-certified-adviser-till-tapper-partners-ab\/'>Acarix AB byter Certified Adviser till Tapper Partners AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml; &ndash; Acarix, ledande inom akustisk- och algoritmbaserad hj&auml;rtdiagnostik, meddelar idag att bolaget byter Certified Adviser till Tapper Partners<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-24 15:15<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-ab-changes-certified-adviser-to-tapper-partners-ab\/'>Acarix AB changes Certified Adviser to Tapper Partners AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that the company is changing its Certified Adviser<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-17 08:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-responds-to-g-ba-decision-on-reimbursement-in-the-german-market\/'>Acarix responds to G-BA decision on reimbursement in the German market<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a negative decision on the<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-09 12:15<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/kallelse-till-extra-bolagsstamma-i-acarix-ab-15\/'>KALLELSE TILL EXTRA BOLAGSST\u00c4MMA I ACARIX AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Aktie&auml;garna i Acarix AB, org.nr 559009-0667 (&rdquo;Bolaget&rdquo;) kallas h&auml;rmed till extra bolagsst&auml;mma m&aring;ndagen den 27 oktober 2025 kl. 11.30 i Advokatfirman<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-09 12:15<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/notice-of-extraordinary-general-meeting-in-acarix-ab\/'>NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACARIX AB<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the &ldquo;Company&rdquo;) are hereby convened to an extraordinary general meeting on Monday 27<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-07 09:31<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-cadscor-system-gains-healthchoice-reimbursement-coverage\/'>Acarix CADScor\u00ae System Gains HealthChoice Reimbursement Coverage<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that HealthChoice, a self-funded insurance<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-09-18 17:04<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-chairman-jan-poulsen-acquires-shares\/'>Acarix Chairman Jan Poulsen Acquires Shares<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>I the period 15. &ndash; 18. September, Jan Poulsen privately purchased 475,000 shares at an average price of SEK 0.3053.<\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-09-08 09:45<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/ceo-purchases-shares-in-acarix-7\/'>CEO purchases shares in Acarix<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix, a leader in AI-driven and acoustics-based cardiac diagnostics, has announced that its President and CEO, Aamir Mahmood, has increased his investment<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-08-21 08:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-reports-significant-progress-toward-fixed-reimbursement\/'>Acarix Reports Significant Progress Toward Fixed Reimbursement<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that the company has achieved another<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-08-21 08:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-publishes-interim-report-january-june-2025\/'>Acarix Publishes Interim Report, January \u2013 June 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden (Aug. 21, 2025) &ndash; Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-08-20 09:45<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/acarix-and-aalborg-university-abstract-accepted-for-aha-2025\/'>Acarix and Aalborg University Abstract Accepted for AHA 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Malm&ouml;, Sweden &ndash; Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that our abstract on the Heart Failure<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-08-18 11:09<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/d.ptpl.dev\/acarix\/invitation-to-presentation-of-acarixs-second-quarter-2025-report\/'>Invitation to presentation of Acarix\u00b4s second quarter 2025 report<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Acarix invites investors, analysts, and media representatives to join a recorded webcast presentation of the second quarter report for 2025, scheduled<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        <\/div><div class='mfn-newsfeed-pagination'><a href='https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/pages\/2956?m-page=1' class='mfn-page-link mfn-page-link-next'>Next<\/a><\/div><\/div><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-80cbca7 e-con-full wd-section-stretch e-flex e-con e-parent\" data-id=\"80cbca7\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-a73cd51 e-con-full ng-image e-flex e-con e-child\" data-id=\"a73cd51\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<\/div>\n\t\t<div class=\"wd-negative-gap elementor-element elementor-element-0a100f5 one-fourth-col e-flex e-con-boxed e-con e-child\" data-id=\"0a100f5\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-167f283 elementor-widget__width-inherit elementor-widget elementor-widget-heading\" data-id=\"167f283\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">About Acarix<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2f2aa7c elementor-widget__width-inherit color-scheme-inherit text-left elementor-widget elementor-widget-text-editor\" data-id=\"2f2aa7c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out.<\/p><p>The CE-mark approved and FDA De Novo cleared Acarix CADScor\u00aeSystem is for patients experiencing stable chest pain with suspected CAD and is designed to help reduce millions of unnecessary and costly diagnostic procedures.<sup>2<\/sup>\u00a0CADScor\u00aeSystem calculates a patient-specific CAD-score non-invasively in 10 minutes with at least 96% confidence (Negative Predictive Value).\u00b9<\/p><p>Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fa12b3c elementor-align-left btn-hover-w elementor-widget elementor-widget-button\" data-id=\"fa12b3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/d.ptpl.dev\/acarix\/about-acarix\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-long-arrow-alt-right\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Learn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"wd-negative-gap elementor-element elementor-element-4ac3529 wd-section-stretch btn-hover-w e-flex e-con-boxed e-con e-parent\" data-id=\"4ac3529\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-12cf3e2 elementor-widget__width-initial elementor-widget-mobile__width-inherit ng-text-center color-scheme-inherit text-left elementor-widget elementor-widget-text-editor\" data-id=\"12cf3e2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ol><li><small><em>User manual US-FDA v.12.Y, prevalence 10,7%<\/em><\/small><\/li><li><small><em>Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, Dilsizian V, Kern MJ, Chandrashekhar Y, Narula J. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging. 2010 Jul;3(7):789-94. doi: 10.1016\/j.jcmg.2010.05.004. PMID: 20633864.<\/em><\/small><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Press Press About Acarix Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease<\/p>\n","protected":false},"author":1,"featured_media":4238,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2956","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Press<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press\" \/>\n<meta property=\"og:description\" content=\"Press Press About Acarix Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/press\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-08T10:08:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/news-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/\",\"name\":\"Press\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/news-scaled.jpg\",\"datePublished\":\"2024-08-10T13:28:11+00:00\",\"dateModified\":\"2026-05-08T10:08:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/news-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/news-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/press\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Press","og_description":"Press Press About Acarix Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease","og_url":"https:\/\/d.ptpl.dev\/acarix\/press\/","og_site_name":"Acarix","article_modified_time":"2026-05-08T10:08:33+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/news-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/press\/","url":"https:\/\/d.ptpl.dev\/acarix\/press\/","name":"Press","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/press\/#primaryimage"},"image":{"@id":"https:\/\/d.ptpl.dev\/acarix\/press\/#primaryimage"},"thumbnailUrl":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/news-scaled.jpg","datePublished":"2024-08-10T13:28:11+00:00","dateModified":"2026-05-08T10:08:33+00:00","breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/press\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/press\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d.ptpl.dev\/acarix\/press\/#primaryimage","url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/news-scaled.jpg","contentUrl":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/news-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/press\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Press"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/pages\/2956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=2956"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/pages\/2956\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=2956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}